Review



red chromagen 3 amino 9 ethyl carbazole aec kit  (Vector Laboratories)


Bioz Verified Symbol Vector Laboratories is a verified supplier
Bioz Manufacturer Symbol Vector Laboratories manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    Vector Laboratories red chromagen 3 amino 9 ethyl carbazole aec kit
    Red Chromagen 3 Amino 9 Ethyl Carbazole Aec Kit, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1264 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/red chromagen 3 amino 9 ethyl carbazole aec kit/product/Vector Laboratories
    Average 96 stars, based on 1264 article reviews
    red chromagen 3 amino 9 ethyl carbazole aec kit - by Bioz Stars, 2026-03
    96/100 stars

    Images



    Similar Products

    red chromagen 3 amino 9 ethyl carbazole aec kit  (Vector Laboratories)
    96
    Vector Laboratories red chromagen 3 amino 9 ethyl carbazole aec kit
    Red Chromagen 3 Amino 9 Ethyl Carbazole Aec Kit, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/red chromagen 3 amino 9 ethyl carbazole aec kit/product/Vector Laboratories
    Average 96 stars, based on 1 article reviews
    red chromagen 3 amino 9 ethyl carbazole aec kit - by Bioz Stars, 2026-03
    96/100 stars
    		  Buy from Supplier
    red chromagen aec  (Vector Laboratories)
    86
    Vector Laboratories red chromagen aec
    Penetration of panitumumab into tumor xenograft tissue is dose and time dependent. Panitumumab initially surrounded the afferent blood supply and then penetrated diffusely into the surrounding tumor tissue. A431 tumor xenograft samples of animals receiving 0, 20, 200, or 500 μg panitumumab were collected (A) 24 hours or (B) 96 hours after initiation of dosing and incubated with anti-idiotype IgG 2 -bound panitumumab to detect administered panitumumab (blue <t>chromagen)</t> and DAKO anti-EGFR to detect EGFR (red chromagen). Micron bars = 10 μm all high magnification images and black arrows identify blood vessels. (C) IHC staining intensities for the anti-idiotype IgG 2 -bound panitumumab were qualitatively graded and plotted as an estimated percent of total staining intensity.
    Red Chromagen Aec, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/red chromagen aec/product/Vector Laboratories
    Average 86 stars, based on 1 article reviews
    red chromagen aec - by Bioz Stars, 2026-03
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    Penetration of panitumumab into tumor xenograft tissue is dose and time dependent. Panitumumab initially surrounded the afferent blood supply and then penetrated diffusely into the surrounding tumor tissue. A431 tumor xenograft samples of animals receiving 0, 20, 200, or 500 μg panitumumab were collected (A) 24 hours or (B) 96 hours after initiation of dosing and incubated with anti-idiotype IgG 2 -bound panitumumab to detect administered panitumumab (blue chromagen) and DAKO anti-EGFR to detect EGFR (red chromagen). Micron bars = 10 μm all high magnification images and black arrows identify blood vessels. (C) IHC staining intensities for the anti-idiotype IgG 2 -bound panitumumab were qualitatively graded and plotted as an estimated percent of total staining intensity.

    Journal: Molecular Cancer

    Article Title: Tumor penetration and epidermal growth factor receptor saturation by panitumumab correlate with antitumor activity in a preclinical model of human cancer

    doi: 10.1186/1476-4598-11-47

    Figure Lengend Snippet: Penetration of panitumumab into tumor xenograft tissue is dose and time dependent. Panitumumab initially surrounded the afferent blood supply and then penetrated diffusely into the surrounding tumor tissue. A431 tumor xenograft samples of animals receiving 0, 20, 200, or 500 μg panitumumab were collected (A) 24 hours or (B) 96 hours after initiation of dosing and incubated with anti-idiotype IgG 2 -bound panitumumab to detect administered panitumumab (blue chromagen) and DAKO anti-EGFR to detect EGFR (red chromagen). Micron bars = 10 μm all high magnification images and black arrows identify blood vessels. (C) IHC staining intensities for the anti-idiotype IgG 2 -bound panitumumab were qualitatively graded and plotted as an estimated percent of total staining intensity.

    Article Snippet: The red chromagen AEC (3-amino-9-ethylcarbazole; Vector Labs, Burlingame, CA) was used to visualize EGFR staining.

    Techniques: Incubation, Immunohistochemistry, Staining